1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow elinogrel: new trials by email Literature Review of elinogrel trials Research Report on elinogrel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment Elinogrel - Renal Impairment | Phase 1 | Terminated | Portola Pharmaceuticals | 44 | 2009-09-01 | 2023-08-04 |
| A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI clopidogrel, PRT060128 - Percutaneous Coronary Intervention | Phase 2 | Completed | Portola Pharmaceuticals | 652 | 2008-12-01 | 2023-08-08 |
United States (2) · Austria (1) · Canada (1) · Germany (1) · Poland (1)
Matthew W McClure, MD (1) · Robert C Welsh, MD (1) · Robert Harrington, MD (1) · Sunil V Rao, MD (1)
2008 (1)